Research News

Research News2022-02-23T09:28:01+11:00

From research grants, to exciting discoveries and treatment breakthroughs, read the latest research news from the Melanoma Institute Australia team as we work tirelessly towards our goal of zero deaths from melanoma.

MIA’s ground-breaking work recognised with two Cancer NSW Awards

November 22nd, 2024|Categories: Research News|Tags: , |

We are proud to announce that the ground-breaking work of the MIA team has been recognised with two prestigious 2024 NSW Premier’s Awards for Outstanding Cancer Research.

Comments Off on MIA’s ground-breaking work recognised with two Cancer NSW Awards

Be part of research study on genetic information and testing

November 15th, 2024|Categories: Research News|Tags: , |

Patients, and families of patients, impacted by advanced melanoma are invited to participate in an online interview to explore their views, experiences, and needs related to genetic information, support and testing.

Comments Off on Be part of research study on genetic information and testing

Together, Amplifying Impact at #AMC2024

October 31st, 2024|Categories: Education, Research News|Tags: , |

Hosted by MIA in Sydney, AMC2024 brought together 776 multidisciplinary delegates to engage in insightful discussions, presentations and workshops, all dedicated to reaching our common goal of zero deaths from melanoma. See our AMC2024 photo album.

Comments Off on Together, Amplifying Impact at #AMC2024

$2.1 million to help boost cancer research in NSW

September 24th, 2024|Categories: Research News|Tags: |

This World Cancer Research Day, the NSW Government is committing $2.1 million in research grant funding, with almost $700k awarded to MIA's Prof Long for an imaging system that will allow researchers to better visualise & understand tumour cell interactions.

Comments Off on $2.1 million to help boost cancer research in NSW

Preventing disease recurrence in BRAF positive melanoma patients

June 20th, 2024|Categories: Research News|Tags: |

Final results of the COMBI-AD clinical trial, published in New England Journal of Medicine, show significant benefit in preventing disease progression in BRAF positive Stage III melanoma patients.

Comments Off on Preventing disease recurrence in BRAF positive melanoma patients
Go to Top